Detalhe da pesquisa
1.
Anxiolytic properties of new chemical entity, 5TIO1.
Neurochem Res
; 38(4): 726-31, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23334713
2.
Evolution of pediatric pharmaceutical forms for treatment of Hansen's disease (leprosy).
Expert Opin Ther Pat
; 33(1): 1-15, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36755421
3.
Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery.
Int J Biol Macromol
; 193(Pt A): 450-456, 2021 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688680
4.
A preformulation study of a new medicine for Chagas disease treatment: physicochemical characterization, thermal stability, and compatibility of benznidazole.
AAPS PharmSciTech
; 11(3): 1391-6, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20824514
5.
Evaluation of antioxidant potencial of novel CaAl and NiAl layered double hydroxides loaded with olanzapine.
Life Sci
; 207: 246-252, 2018 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29778806
6.
Enhancement of dissolution rate through eutectic mixture and solid solution of posaconazole and benznidazole.
Int J Pharm
; 525(1): 32-42, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412452
7.
Multicomponent systems with cyclodextrins and hydrophilic polymers for the delivery of Efavirenz.
Carbohydr Polym
; 130: 133-40, 2015 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26076609
8.
Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods.
Carbohydr Polym
; 104: 166-74, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24607174